1,642
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Antiproliferative and antibacterial activity of some glutarimide derivatives

, , , &
Pages 915-923 | Received 07 May 2015, Accepted 26 Jun 2015, Published online: 06 Aug 2015

Figures & data

Figure 1. Structures of glutarimide derivatives 19.

Figure 1. Structures of glutarimide derivatives 1–9.

Scheme 1. Synthetic path to obtain compounds 1 and 2.

Scheme 1. Synthetic path to obtain compounds 1 and 2.

Scheme 2. Synthetic paths to obtain compounds (A) 36; and (B) 79.

Scheme 2. Synthetic paths to obtain compounds (A) 3–6; and (B) 7–9.

Table 1. Concentrations of compounds 19 that induced 50% decrease in cell survival (IC50).

Figure 2. Dose–response curves for the cytotoxicity of compound 7 toward HeLa, K562, MDA-MB-453 and MRC-5 cells. Percentage of viable cells (S%) was plotted against various concentrations of compound 7.

Figure 2. Dose–response curves for the cytotoxicity of compound 7 toward HeLa, K562, MDA-MB-453 and MRC-5 cells. Percentage of viable cells (S%) was plotted against various concentrations of compound 7.

Figure 3. Heatmap depiction of descriptors (auto- and cross-correlograms), calculated by AMANDA algorithm, for compounds 1–9.

Figure 3. Heatmap depiction of descriptors (auto- and cross-correlograms), calculated by AMANDA algorithm, for compounds 1–9.

Table 2. Antibacterial activity of compounds 1, 2, 4, 68 and 9, determined by the disk diffusion method.

Table 3. Antibacterial activity of compounds 1, 2, 4, 6–8 and 9 expressed as MIC (mg/mL), determined by the broth microdilution method.

Supplemental material

IENZ_1070844_Supp.pdf

Download PDF (4.4 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.